Most cited papers from Allergan (United States)

Allergan (United States)

What are the most cited papers from Allergan (United States)?

The most cited paper from Allergan (United States) is "Global Prevalence and Major Risk Factors of Diabetic Retinopathy" (Joanne Wen Yee Yau et al., 2012), with 5,033 citations. Next come "Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations" (3,496) and "The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia" (1,170).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 339 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Global Prevalence and Major Risk Factors of Diabetic Retinopathy Joanne Wen Yee Yau et al. · Diabetes Care Open access	2 Feb 2012	5,033
2	Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations Robert H. Dworkin et al. · Journal of Pain Open access	13 Dec 2007	3,496
3	The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia Sophie Rogers, Rachel L. McIntosh, Ning Cheung et al. · Ophthalmology Open access	18 Dec 2009	1,170
4	Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema David S. Boyer, Young Hee Yoon, Rubens Belfort et al. · Ophthalmology Open access	4 Jun 2014	1,137
5	Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion Julia A. Haller, Francesco Maria Bandello, Rubens Belfort et al. · Ophthalmology	26 Apr 2010	1,076
6	OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial SK Aurora, DW Dodick, CC Turkel et al. · Cephalalgia Open access	17 Mar 2010	1,058
7	OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain	7 May 2010	1,006
8	OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial HC Diener, DW Dodick, SK Aurora et al. · Cephalalgia	17 Mar 2010	973
9	Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626. Kenneth N. Sall, Onex Dara Stevenson, Thomas K. Mundorf et al. · Ophthalmology	Apr 2000	918
10	The Pathology of Dry Eye Michael Ethan Stern, Roger Wilmer Beuerman, Robert I. Fox et al. · Cornea	Nov 1998	812
11	Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinases Arup Kumar Indra, Xavier Warot, Jacques Brocard et al. · Nucleic Acids Research Open access	Nov 1999	771
12	Global prevalence of chronic migraine: A systematic review JL Natoli, AN Manack, Bonnie B. Dean et al. · Cephalalgia Review	10 Jul 2009	714
13	A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis Scott L. Friedman et al. · Hepatology Open access	17 Aug 2017	676
14	Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion Julia A. Haller, Francesco Maria Bandello, Rubens Belfort et al. · Ophthalmology	24 Jul 2011	676
15	Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) AM Blumenfeld, SF Varon, TK Wilcox et al. · Cephalalgia	2 Sep 2010	650
16	US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey David R. Strutton, Jonathan W. Kowalski, PharmD et al. · Journal of the American Academy of Dermatology	27 Jul 2004	642
17	Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers Dawn C. Buse, AN Manack, Daniel Serrano et al. · Journal of Neurology Neurosurgery & Psychiatry Open access	17 Feb 2010	628
18	Role of carnitine in disease Judith Flanagan, Peter A. Simmons, Joseph G. Vehige et al. · Nutrition & Metabolism Open access	2010	624
19	Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant Joan-En Chang-Lin, Mayssa Attar, Andrew Acheampong et al. · Investigative Ophthalmology & Visual Science	11 Aug 2010	601
20	Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review Rachel L. McIntosh, Sophie Rogers, Lyndell L. Lim et al. · Ophthalmology Review	May 2010	598
21	The role of the lacrimal functional unit in the pathophysiology of dry eye Michael Ethan Stern, Jianping Gao, Karyn F. Siemasko et al. · Experimental Eye Research	20 Nov 2003	579
22	Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine Min Suk Yang, Regina Rendas‐Baum, Sepideh F. Varon et al. · Cephalalgia Open access	6 Sep 2010	567
23	Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis Oliver Krenkel, Tobias Puengel, Olivier Govaere et al. · Hepatology	21 Sep 2017	564
24	Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study Dawn C. Buse, Aubrey N. Manack, Kristina M. Fanning et al. · Headache The Journal of Head and Face Pain	22 Jun 2012	558
25	Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles Henry G. Morrison, Changquan Calvin Sun, Sesha Neervannan · International Journal of Pharmaceutics	28 May 2009	544
26	Evaluation of amorphous solid dispersion properties using thermal analysis techniques Jared A. Baird, Lynne S. Taylor · Advanced Drug Delivery Reviews Review	6 Aug 2011	505
27	Tear Cytokine Profiles in Dysfunctional Tear Syndrome Helene Y Lam, Lauren Bleiden, Cintia Sade de Paiva et al. · American Journal of Ophthalmology Open access	10 Nov 2008	498
28	Categorizing the Stage of Glaucoma From Pre-Diagnosis to End-Stage Disease Richard A. Mills, Donald L. Budenz, Paul P. Lee et al. · American Journal of Ophthalmology	30 Dec 2005	490
29	Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial Francisco Cruz, Sender Herschorn, Philip J. Aliotta et al. · European Urology	21 Jul 2011	473
30	Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye Cintia Sade de Paiva, Rosa M. Corrales, Arturo Villarreal et al. · Experimental Eye Research	3 May 2006	450
31	Adherence to oral migraine-preventive medications among patients with chronic migraine Zsolt Hepp, David W. Dodick, Sepideh F. Varon et al. · Cephalalgia	27 Aug 2014	441
32	Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review Sophie Rogers, Rachel L. McIntosh, Lyndell L. Lim et al. · Ophthalmology Review	May 2010	433
33	IL-17 disrupts corneal barrier following desiccating stress Cintia Sade de Paiva, Suksri Chotikavanich, Solherny B. Pangelinan et al. · Mucosal Immunology Open access	25 Feb 2009	425
34	Efficacy and safety of cyclosporin a ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease Dara Stevenson, Joseph Tauber, Brenda L. Reis · Ophthalmology	May 2000	424
35	OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial Christopher Reginald Chapple, Karl‐Dietrich Sievert, SCOTT A. MacDIARMID et al. · European Urology	10 Apr 2013	415
36	OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial Victor W. Νitti, Roger Roman Dmochowski, Sender Herschorn et al. · The Journal of Urology	14 Dec 2012	411
37	The Facial Aging Process From the “Inside Out” Arthur Swift, Steven Liew, Susan H. Weinkle et al. · Aesthetic Surgery Journal Open access	16 Dec 2020	409
38	Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial Roger Roman Dmochowski, Christopher Reginald Chapple, Victor W. Νitti et al. · The Journal of Urology	17 Oct 2010	405
39	Recommendations for the use of botulinum toxin type A in the management of cerebral palsy H. Kerr Graham, Kei Roger Aoki, Ilona Autti‐Rämö et al. · Gait & Posture	Feb 2000	405
40	Topical and systemic drug delivery to the posterior segments Pamela Hughes, O Olejník, Joan-En Chang-Lin et al. · Advanced Drug Delivery Reviews	11 Nov 2005	402
41	Psychiatric comorbidities of episodic and chronic migraine Dawn C. Buse, Stephen David Silberstein, Aubrey N. Manack et al. · Journal of Neurology	6 Nov 2012	397
42	Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program John E. Mazuski, Leanne B. Gasink, Jon M. Armstrong et al. · Clinical Infectious Diseases Open access	8 Mar 2016	394
43	Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( IBMS‐II ) Andrew M. Blumenfeld, Lisa M. Bloudek, Werner J. Becker et al. · Headache The Journal of Head and Face Pain	4 Jan 2013	392
44	Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin et al. · Pain	9 Mar 2010	386
45	Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study Vlad Ratziu, Arun Jayant Sanyal, Stephen A. Harrison et al. · Hepatology Open access	13 Jan 2020	377
46	Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis Zsolt Hepp, David W. Dodick, Sepideh F. Varon et al. · Cephalalgia Open access	11 Nov 2016	373
47	Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome Cintia Sade de Paiva, Dan B. Jones, Michael Ethan Stern et al. · Scientific Reports Open access	18 Apr 2016	371
48	Utility assessment among patients with dry eye disease Rhett M. Schiffman, John G. Walt, Gordon Jacobsen et al. · Ophthalmology	Jul 2003	365
49	DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS David S. Boyer, David Faber, Sunil R. Gupta et al. · Retina	12 Apr 2011	362
50	Piphillin: Improved Prediction of Metagenomic Content by Direct Inference from Human Microbiomes Shoko Iwai, Thomas Weinmaier, Brian L. Schmidt et al. · PLoS ONE Open access	7 Nov 2016	359

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.